These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8293765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N, Lugnier C, Stoclet JC.
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [Abstract] [Full Text] [Related]

  • 3. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE, Lugnier C.
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [Abstract] [Full Text] [Related]

  • 4. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
    Stoclet JC.
    Z Kardiol; 1991 Oct; 80 Suppl 7():87-90. PubMed ID: 1665267
    [Abstract] [Full Text] [Related]

  • 5. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [Abstract] [Full Text] [Related]

  • 6. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ, Cairrão E, Morgado M, Alvarez E, Verde I.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):102-9. PubMed ID: 18234184
    [Abstract] [Full Text] [Related]

  • 7. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL, Conanan ND.
    J Pharmacol Exp Ther; 1995 Mar 17; 272(3):997-1004. PubMed ID: 7891355
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves.
    Uckert S, Oelke M, Waldkirch E, Stief CG, Albrecht K, Tröger HD, Jonas U, Andersson KE, Hedlund P.
    Urology; 2005 Mar 17; 65(3):604-10. PubMed ID: 15780401
    [Abstract] [Full Text] [Related]

  • 10. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M, Otten A, Frölich JC, Förstermann U.
    J Pharmacol Exp Ther; 1991 Feb 17; 256(2):677-82. PubMed ID: 1847208
    [Abstract] [Full Text] [Related]

  • 11. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
    Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW.
    J Pharmacol Exp Ther; 1993 Jun 17; 265(3):1213-23. PubMed ID: 8389856
    [Abstract] [Full Text] [Related]

  • 12. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM, Kuo SC.
    Br J Pharmacol; 1995 Apr 17; 114(8):1587-94. PubMed ID: 7599926
    [Abstract] [Full Text] [Related]

  • 13. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A, Martin V, Lugnier C.
    Br J Pharmacol; 1997 Sep 17; 122(1):158-64. PubMed ID: 9298542
    [Abstract] [Full Text] [Related]

  • 14. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C, Keravis T, Eckly-Michel A.
    J Physiol Pharmacol; 1999 Dec 17; 50(4):639-52. PubMed ID: 10639014
    [Abstract] [Full Text] [Related]

  • 15. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
    Nicholson CD, Shahid M, Bruin J, Barron E, Spiers I, de Boer J, van Amsterdam RG, Zaagsma J, Kelly JJ, Dent G.
    J Pharmacol Exp Ther; 1995 Aug 17; 274(2):678-87. PubMed ID: 7636728
    [Abstract] [Full Text] [Related]

  • 16. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC.
    Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708
    [Abstract] [Full Text] [Related]

  • 17. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ, Liu H, Palmer D, Maurice DH.
    Br J Pharmacol; 1997 Sep 15; 122(2):233-40. PubMed ID: 9313930
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
    Silver PJ, Lepore RE, O'Connor B, Lemp BM, Hamel LT, Bentley RG, Harris AL.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):34-42. PubMed ID: 2845058
    [Abstract] [Full Text] [Related]

  • 19. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation.
    Karsten AJ, Derouet H, Ziegler M, Eckert RE.
    Urol Res; 2003 Feb 15; 30(6):367-73. PubMed ID: 12599016
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
    Werkström V, Svensson A, Andersson KE, Hedlund P.
    BJU Int; 2006 Aug 15; 98(2):414-23. PubMed ID: 16626307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.